Stockreport

Savara Provides Regulatory Update on the MOLBREEVI* Development Program in Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune PAP) [Yahoo! Finance]

Savara, Inc.  (SVRA) 
Last savara, inc. earnings: 3/12 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: savarapharma.com/investors/events-presentations
PDF -- Company has Submitted the Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) -- -- Submission of the MAA to the U.K. Medicines and He [Read more]